Replimune Group
REPL
77 hedge funds and large institutions have $631M invested in Replimune Group in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 4 closing their positions.
525% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 4
271% more capital inflows, than outflows
Capital inflows: $83.5M | Capital outflows: $22.5M
177% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 13
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
38% more funds holding
Funds holding: 56 → 77 (+21)
8.62% more ownership
Funds ownership: 60.5% → 69.12% (+8.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$11.9M |
| 2 |
Corriente Advisors
Fort Worth,
Texas
|
+$8.58M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$8.41M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.85M |
| 5 |
BVF Inc
San Francisco,
California
|
+$6.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$12M |
| 2 |
Marshall Wace North America
New York
|
-$3.37M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.87M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$693K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$596K |
REPL Hedge Fund Activity: Q2 2020 in Review
77 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2020, worth a combined $631M — up 186% from $221M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new REPL positions and 4 closed out — a net gain of 21 holders — while 36 added to existing stakes and 13 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $11.9M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $12M.
- 77 institutional investors held Replimune Group (REPL) as of Q2 2020, up from 56 in Q1 2020.
- Funds reported $631M of Replimune Group stock for Q2 2020, up 186% quarter-over-quarter.
- 25 funds opened new Replimune Group positions in Q2 2020 and 4 closed out, a net change of +21 holders.
- The largest Replimune Group buyer in Q2 2020 was Victory Capital Management, an estimated $11.9M added.
- The largest Replimune Group seller in Q2 2020 was Bain Capital Life Sciences Investors, an estimated $12M sold.
Based on aggregated 13F filings for Q2 2020.